Virbac has announced that it is to increase production of cat vaccines at its French plants to help practices in the UK manage a shortfall in supply.
The predicted shortfall follows warnings by other manufacturers of stock shortages of between three and six months.
Virbac, which makes the Feligen RCP, Leucogen and Leucofeligen cat vaccines, says it wants to reassure practices that it will do its utmost to ensure continuity of supply during this period and is urging them to order as usual and not stockpile product, which could exacerbate the problem.
Simon Boulton MRCVS, Product Manager for Virbac's vaccine range, said: "Our priority is to keep stock flowing to our existing customers. With this in mind, we've now ceased to supply wholesalers with our cat vaccines. Once wholesaler stocks have been depleted, we ask customers to contact us directly so that stock can be despatched to them from our own warehouse.
By taking this step, we can manage our own stocks effectively and, while we'll be putting our existing customers first, we also stand ready to help supply the rest of the veterinary sector during this period. As a primary manufacturer of vaccines, we're well placed to react quickly to stock shortages and expect to have significantly increased supply by November."
Practices wanting further information should contact their Virbac Territory Manager. Direct orders to the company should be made by calling Virbac on 01359 243243 and selecting Option Three (Direct Orders).
The RCVS Veterinary Nurses Council has celebrated the 50th anniversary of veterinary nursing at the House of Commons with a call for statutory regulation for the profession.
At a Golden Jubilee event hosted by Mr Roger Gale MP, Veterinary Nurses Council Chairman Liz Branscombe drew attention to the fact that there is no legal protection for the title 'veterinary nurse', despite qualified nurses playing "a unique role in the practice team".
This effectively means that anyone could work in a veterinary practice as a nurse, without taking the three- or four-year training required for Listed or Registered Veterinary Nurses.
Liz said: "We believe that the nation's animals and their owners deserve better than this. And it's not just a question of animal welfare: public health is at risk from the incorrect use of medicines - for example, the well documented development of antimicrobial resistance."
The Veterinary Surgeons Act 1966 was put in place only five years after the introduction of veterinary nurse training and too soon to fully recognise the potential of veterinary nursing as a profession in its own right.
As an interim measure, the RCVS has put in place a non-statutory Register for Veterinary Nurses, to which 86% of eligible nurses have signed up. Registered Veterinary Nurses agree to follow a code of conduct, keep their skills and knowledge up to date and abide by a disciplinary system. However, it is not possible for the College to bar those removed from the Register for serious professional misconduct from working as a veterinary nurse.
The Register also does not address the misuse of the title 'veterinary nurse' by unqualified people.
Liz asked MPs present at the House of Commons reception to sign up to an Early Day Motion tabled by Andrew Rosindell MP, which calls for statutory regulation for the veterinary nursing profession.
Others are urged to sign a petition on the Government's website which has been mounted by the British Veterinary Nursing Association and is supported by the College and the British Veterinary Association: http://epetitions.direct.gov.uk/petitions/18700.
The issues are being considered by the RCVS Veterinary Nurses Legislation Working Party and the group's recommendations will feed into the wider work of the RCVS Legislation Working Party, which will be reporting to the Defra Minister of State in the summer of 2012 with proposals as to how statutory regulation could be provided for a range of veterinary services, including veterinary nursing.
Woodley Equipment Company Ltd has announced the launch of InSight rapid diagnostic test kits. The test range includes FeLV, FIV, FeLV-FIV Combi, Giardia, Canine Heartworm, Canine Parvovirus and with more tests in development.
The test kits are available to veterinary practices across the UK and to Woodley's global veterinary diagnostic distributors. Each test is based on a sandwich lateral flow immunochromatographic assay and contains 10 cassettes per box. The company says that the diagnostic kits are simple and easy to use and will provide point of care testing direct to the veterinary practice. The kits are stored at room temperature (2⁰C - 30⁰C).
The range of InSight Rapid Diagnostic Tests includes:
To place an order, email sales@woodleyequipment.com, fax 01204 669034, or telephone 01204 669033.
For more information, visit: http://www.woodleyequipment.com/.
Bayer Animal Health is to hold a free webinar for companion animal veterinary surgeons about its new fluoroquinolone for cats and dogs, Veraflox.
The one-hour webinar begins with a talk on mutant prevention concentration (MPC) from Dr Joe Blondeau, head of clinical microbiology at the Royal University Hospital & the Saskatoon Health Region, in Canada. He's followed by Dr E Bensignor, President of the European College of Veterinary Dermatology, who will present the findings of clinical studies. The final presentation by Dr Joy Olsen, global veterinary services manager for Bayer Animal Health, reviews the features and characteristics of Veraflox (pradofloxacin) and its use in cats and dogs.
The webinar can be watched live on Tuesday 25 October at 7:30pm, when you'll have the opportunity to put questions to the speakers. Alternatively, a recording of the event can be viewed at any point afterwards.
To register, visit http://nl.webcast3.animalhealth.be/nl/english-subscription#ht=944, to receive a login name and password.
For further information on Veraflox, contact your Bayer representative or call 01635 563000.
The British Veterinary Association has criticised the conclusions drawn by the Gloucestershire Wildlife Trust in its report on badger vaccine deployment.
The report considers the effectiveness of the Trust's programme of deploying the injectable BadgerBCG vaccine in seven nature reserves covering only 170 hectares (1.7 sq km) during the summer.
It concludes that the badger vaccine is a viable alternative to culling in the battle against bovine TB, but according to the BVA, does not give evidence to support this claim.
Carl Padgett, President of the BVA, said: "We welcome the initiative by the Gloucestershire Wildlife Trust to investigate the deployment of the badger vaccine but this work must not be confused with an investigation into the effectiveness of the badger vaccine in reducing or eradicating bovine TB.
"To conclude from this report that the badger vaccine is a viable alternative to culling in eradicating TB is unrealistic at best and spin at worst.
"The fact remains that the vaccine has no protective effect on infected badgers and we know that at least 30-40% of badgers within an area will be infected. Many young badgers will be infected before they can be trapped and injected.
"In terms of the practicalities of deployment this report provides interesting information but we will learn much more as a result of Defra's Badger Vaccine Deployment Project which is looking at a much larger area of 100 sq km.
"Vaccination of badgers certainly has a role to play in an effective TB eradication programme but it is only one tool in the toolbox."
The BSAVA has launched a new app for iPhone / Android users, the Guide to Procedures in Small Animal Practice.
The guide, which is aimed at vets and students, covers more than 70 of the diagnostic and therapeutic procedures commonly performed in small animal veterinary practice.
The Association says it always planned to extend the number of digital member benefits, but has been spurred on by feedback about its Formulary app, like this comment from 'talland' on the iTunes store: "Absolutely fantastic App - in some ways even easier to use than the book itself. Well done BSAVA. It'd be great if the Guide to Procedures in Small Animal Practice could be an App too".
The BSAVA says the key features of the new app are:
Once installed on your phone you will need to launch the Application by entering a unique activation code which can be obtained from the App Activation Code page (member login required).
Hill's has launched 'Lose 60 Tonnes in 6 months', a campaign to help clients get their pet to a healthy weight.
Sixty tonnes is equivalent to the weight of twelve elephants, which is a huge target. Hill's says that if every practice makes a small contribution, it can be achieved.
Hill's support includes a public relations pack which the company says contains everything veterinary surgeons and nurses need to help raise awareness and encourage pet owners to bring their pets in for a weight assessment. The pack includes proforma press releases and guidance on how to cultivate a mutually beneficial relationship with local media. There is also a 'Lose 60 tonnes in 6 months' point of sale kit that includes a poster, stickers and a noticeboard kit for clinics, to drive awareness while clients wait for consults.
As part of the campaign, Hill's is also hosting a series of nurse webinars on weight management and offering additional support material such as consult room posters, weight clinic packs and pet tape measures, an item often requested by nurses. There are also promotional offers available through Hill's Territory Managers, subject to stock availability.
Hill's Customer Marketing Manager, Sara Locke MRCVS said: "We feel it is important to support practices at the grass-roots level and to develop a campaign that will have real meaning within the local community. I hope practices will get behind it, engage with pet owners and as a result, gain new clients. They are also helping thousands of pets live longer and happier lives."
Further information is available from local Hill's Territory Managers or by calling Hill's on 0800 242438 or in ROI 1 800 626002.
Vetoquinol is launching Cimalgex, a new NSAID for dogs this month.
Cimalgex (cimicoxib) is a new second generation COX-2 inhibitor which can be used for the treatment of pain and inflammation due to osteoarthritis and the management of peri-operative pain associated with orthopaedic and soft tissue surgery, for which it can be given two hours before surgery and continued for 3-7 days post surgery.
Vetoquinol says that an important consideration in treating dogs with osteoarthritis, many of which are geriatric, is that there are no contraindications to using Cimalgex in patients with mild to moderate renal impairment.
According to the company, field trials showed that over 90 per cent of per owners and vets identified that animals experienced excellent analgesia post operatively*.
Available in a chewable, splitable tablet, Cimalgex can be given with or without food.
Vetoquinol says that the excellent tolerability, efficacy profile and ease of use of Cimalgex means that veterinary patients could benefit from pain relief in situations where clinicians are worried about the risks versus the benefits of prescribing a NSAID for pain management.
Further information about assessing pain and decision making when it comes to prescribing NSAIDs, will be presented in a free webinar on 19th October at 8.30pm. To register go to www.thewebinarvet.com/vetoquinol and enter code CIM1.
Reference*E. Grandemange: Field evaluation of the efficacy and the safety of cimicoxib in the relief of peri-operative pain in dogs; 2008, study number n°3008C2F1
Free veterinary careers materials are available from the Royal College of Veterinary Surgeons for vets going back to school to give careers talks.
Freda Andrews, Head of Education said: "We know that, although veterinary surgeons are busy people, they often say yes when schools ask them to give careers talks. "Since September last year we've responded to around 500 requests for our 'Veterinary Science...for all Walks of Life' careers information. If you are giving a talk, these are well worth a look."
Comprising a printed booklet and a series of short videos available online, the careers materials were produced by the RCVS in collaboration with the vet schools and with government funding. They aim to show the variety both in veterinary work, and in vets themselves, to encourage teenagers from all backgrounds to consider aiming for a career in veterinary medicine. The videos can also be watched on the VetCareers channel on YouTube.
Each video features a vet working in a different field within veterinary medicine, and the brochure contains information about different types of veterinary careers, routes into the vet schools, and the entry requirements. Anyone who is in a position to advise aspiring vet students on the university entry requirements needs to be aware that there are now a variety of different routes into vet school, including options for students with vocational qualifications such as BTEC Diplomas, and pre-entry or foundation years aimed at increasing the diversity of the student population.
A new careers leaflet will also shortly be available from the RCVS to encourage would-be veterinary nurses, and will include the new RCVS Level 3 VN Diploma and the mixed-practice route to qualification newly introduced by the RCVS.
Freda said: "Veterinary surgeons can come from all walks of life - as our careers materials show. It's important that the profession reflects the population it serves and for teenagers to have good advice about veterinary careers and how to get into the profession. So, if you're going back to school to encourage the next generation, then get in touch!"
Free hard-copies of the brochure are available by contacting the RCVS Education Department (education@rcvs.org.uk or 020 7202 0791). An interactive version of the booklet can be found at http://www.walksoflife.org.uk/, and individual videos viewed at http://www.youtube.com/vetcareers.
Bayer Animal Health has launched a next generation fluoroquinolone antimicrobial - Veraflox (pradofloxacin) - for the treatment of bacterial infections in cats and dogs.
Bayer Animal Health's marketing manager Dr Markus Edingloh said: "Veraflox, with its molecular compound pradofloxacin, developed exclusively for veterinary medicine, marks a major leap forward in veterinary antibiotic therapy and patient care.
"Veraflox has an enhanced spectrum of antimicrobial activity which encompasses Gram-positive and anaerobic bacteria. In addition, Veraflox has demonstrated high levels of bactericidal activity against target pathogens including activity against dormant bacteria typically found in chronic infections."
For cats, an oral suspension is available in which a fine-grained ion exchange agent binds to the antibiotic, apparently allowing it to pass the cat's taste buds undetected. Bayer says this innovation has been adopted specifically to ensure the product is palatable to cats, and help ensure owner compliance. The oral suspension comes with a syringe with both millilitre and gramme graduations, to help ensure accurate dosing.
Veraflox oral suspension is indicated for the treatment of upper respiratory tract infections, wound infections and abscesses. The 15mg tablet is also licensed in cats for treating upper respiratory tract infections.
Bayer says that in addition to its other indications, Veraflox is also very effective at combatting anaerobic bacteria that play a major role in aggressive bone destruction in canine periodontal disease, and it is the first fluoroquinolone to be licensed in dogs for the adjunctive treatment of severe infections of the gingiva and periodontal tissues.
In addition to its dental claim for dogs, Veraflox is also indicated for the treatment of wound infections, superficial and deep pyoderma, and acute urinary tract infections. It is given to dogs as a once-daily flavoured tablet.
Dr Edingloh added: "The unique chemistry and way in which Veraflox works gives it superior antibacterial activity compared with existing fluoroquinolones. In addition, during field studies, Veraflox was shown to be superior to other leading antibiotic products.
"Pradofloxacin has been proven to have a wide spectrum of activity, outstanding antibacterial activity, and an excellent safety margin. Its pharmacokinetic features ensure this active ingredient can rapidly get to the site of infection, at which it has a great impact on the pathogen population.
"One of the most common reasons for treatment failure where antibiotics are concerned is lack of owner compliance. The availability of Veraflox as an oral suspension with a graded syringe for cats, will enable more accurate dosing, far easier administration and so ensure higher cure rates.
"The launch of Veraflox is the first major advance in its class, since the introduction of Baytril, the first veterinary fluoroquinolone, over 20 years ago. Veraflox provides vets with more predictability, reliability and peace of mind, especially in difficult to treat infections."
For further information on Veraflox, please contact your Bayer representative or call 01635 563000.
A survey of 246 veterinary surgeons and nurses attending a lunch and learn webinar sponsored by Supreme Petfoods has revealed that they rate high fibre as the most important factor in making a recommendation for rabbit or guinea pig food.
High fibre was the top factor for 53% of respondents and rated as being much more important than monocomponent kibbles (27%), or a recommendation by an exotics expert (18%).
Supreme says it has addressed this concern by increasing the fibre content of its Science Selective Rabbit food to 23% fibre - the highest of any concentrate for small furries in the UK. The new VetCarePlus range, based on the monoforage technology developed by the company, contains up to 34% fibre. Fibre is vital for small furries, playing an active role in gastro intestinal health, dental health, weight management and behavioural factors.
The survey also revealed that vets and nurses are feeling optimistic about the impact of small furries on veterinary practice. 70% of respondents felt that, even in the face of the recent recession, small furries/exotics had made a growing contribution to their business profits over the last five years and 90% felt that there was potential for them to make an even bigger contribution to practice profits in the future. The biggest barrier to more small pets being brought forward for treatment was felt to be the cost of treatment relative to the cost of the pet - 55% felt that this was the most significant stumbling block - but another 45% felt that lack of education and an inability to recognise illness were the main factors.
Supreme's Marketing Manager Claire Hamblion has recently launched a trial programme in a limited number of practices to provide the tools needed to help grow the small pets sector. She said: "Our experience to date indicates that having the right tools and providing a warm welcome to owners of small furries that projects a willingness to treat them, can make a difference. We would love to hear more from those who have successfully grown this part of their business and those who are looking to expand their capabilities in this exciting area." Interested parties, or those who would like to pre-register for the further roll out of Supreme's business programme can send an email with their contact details to b2b@supremepetfoods.com.
The company says it has been delighted by the positive response to its lunch and learn webinar format, and more events are being scheduled for the winter months. Those interested in attending future events, or receiving educational material, can register their interest by email at cpd@supremepetfoods.com to receive priority notification of dates and availability.
Norbrook has launched a new iPhone app designed to give veterinary professionals essential pharmaceutical product information at the touch of a button.
The Norbrook Veterinary Excellence Tool includes information on the company's full range of animal health medicines including pharmaceutical presentation, uses, dosage and administration, withdrawal periods, contraindications & warnings and pharmaceutical precautions.
Mr Jorge Rodrigues, General Manager at Norbrook said: "Norbrook is committed to providing the best possible service to our customers. Time is a precious commodity for veterinary professionals and with the range of products on the market it can be very time-consuming to access essential product information. We have designed the Norbrook VET app to give our customers a quick and easy reference tool for all our products with the facility to filter searches for product information by species, category or brand. And of course the beauty of the iPhone app is that the information is accessible anytime, anywhere so if a customer is out at a client's premises, in their practice or at home, the information is readily available."
The Norbrook VET app also has a facility which will keep users up-to-date with relevant industry and company news and a dedicated Contact Us section which will allow customers better communication channels with the company.
Katie Norton, Web SEO Marketing Co-ordinator said: "It is our intention that the Norbrook VET app will become a key communication channel with our customers. The app will be updated regularly and we will continue to add new features to enhance the service we offer to our valued customers."
The Norbrook VET iPhone App is available to download direct from the iTunes store.
The BSAVA reports that within 20 minutes of the opening of enrolment for its Medicine and Surgery certificates at 9:00am yesterday, both courses were filled and a waiting list had been established.
According to the BSAVA, interest in the courses had been flooding in over recent months, however the number of applications still surprised the Education team, led by Dr Frances Barr.
She said: "There was a lot of confidence in this programme from the start, and we had lots of people requesting information, but until yesterday we did not know for certain that we would meet the maximum number of 30 delegates on each Certificate. So to have a waiting list and pre-registration requests for 2013 is fantastic. As veterinary professionals we want to strive for clinical excellence, to have our achievements recognised, and be encouraged and supported on the way there. This is what BSAVA aims to do with the medicine and surgery certificates".
For more information about all BSAVA CPD visit http://www.bsava.com/ or call 01452 726700.
Parasitologists from ESCCAP (European Scientific Counsel Companion Animal Parasites) have been voicing their concern over the implications of the imminent changes to the UK's DEFRA-run Pet Travel Scheme (PETS).
Under the new regulations, which take effect from Jan 2012, tick control will no longer be mandatory. According to ESCCAP, a recent study has demonstrated that a population of exotic tick species has already become established in the south-east of England1. With up to 15,000 animals travelling under PETS each month, the possibility of exotic ticks (and their associated tick-borne diseases) entering and establishing in the UK becomes increasingly likely. The European Parliament has yet to rule on mandatory tapeworm control. The decision will impact on the future distribution of, and disease threat from, Echinococcus multilocularis.
ESCCAP UK is advising all veterinary surgeons to discuss the risks with their clients and to ensure they make an informed decision about tick control when the new legislation comes into effect.
In addition, the UK branch of ESCCAP is holding a free seminar in Bristol on 28th October to highlight the role that veterinary practices can play in helping clients understand how the changes could impact upon their pet's health.
ESCCAP says the seminar will provide all the information clinicians need to have an informed dialogue with clients. Presentations will provide an overview of the impact of the changes to PETS in relation to rabies, Echinococcus and ticks, as well as advice about how to communicate the information to pet owners and the tools and support available.
Additional support includes ESCCAP UK's website http://www.esccapuk.org.uk/, which offers updates on the PETS situation, guidelines for parasite control programmes and podcasts for veterinary surgeons, nurses and pet owners.
The seminar takes place at Engineers' House, The Promenade, Clifton Down, Bristol BS8 3NB.
To register, telephone: 01684 568998, or email: info@esccapuk.org.uk
Reference1. Smith F D, Ballantyne R, Morgan E R, Wall R (2011) Prevalence, distribution and risk associated with tick infestation of dogs in Great Britain. Medical and Veterinary Entomology. doi: 10.1111/j.1365-2915.2011.00954.x
Merial Animal Health is inviting practitioners to submit original clinical pain management cases for The Previcox & Equioxx European Clinical Case Award for Excellence.
Set up last year, the award recognises excellence in pain management in companion animals and horses. Submitted cases will be evaluated for successful management of pain associated with osteoarthritis, surgery or other conditions in companion animals and horses using firocoxib.
Two winners will be selected and each awarded €1,000 and an invitation to present their clinical case during Merial's next European Pain Management Symposium in 2012, with all travel and accommodation expenses paid.
Open to all veterinary practitioners, the deadline for submission is December 1st 2011. For an application form please email agate.vanopstal@merial.com
CPD Solutions has launched four topic-specific veterinary webinar clubs for the veterinary profession, available to view at www.veterinarywebinars.com.
For veterinary surgeons, there are three clubs, one focussing on neurology, another on orthopaedics, and a final one on small animal practice. There is a fourth webinar club for veterinary nurses and technicians.
Susie Coughlan, Managing Director at CPD Solutions said: "We have given a lot of thought to setting up these clubs so that they reflect what people really need from their CPD. Neurology and orthopaedics are always incredibly popular topics and many vets have told us that they feel that in these subject areas, rapid developments and new techniques can really change their approach to cases."
Each club provides a monthly live webinar, in afternoons or evenings and all webinars are available for club members to view after the live event at their convenience. Susie said: "We decided to limit the available webinars to one a month during the annual membership period because with the best will in the world, many vets and nurses have only a limited time available to spend on CPD and there is very little point in paying for a multitude of webinars that they will never have the time to attend. Part of the appeal of webinars is their low cost and value for money, although we know many vets and nurses put flexibility as to when and where they view as the most exciting attribute of webinar clubs."
CPD Solutions is offering a special launch price of £247 + VAT to anyone who joins a webinar club for one year before 10th October (after which, the price rises to £327 + VAT per club). The offer includes a free CD/DVD which the company says is packed with content relevant to the club topic. All members can also access the full back catalogue of webinars relating to the topic.
For more details or to join a webinar club visit www.veterinarywebinars.com or call 0151 328 0444.
Pfizer is giving away a free equine weigh tape with every purchase of Equest & Equest Pramox (while stocks last), to help encourage accurate treatment against encysted small redworms this season.
According to the company, Equest & Equest Pramox are the only wormers in the UK that treat encysted small redworm in a single dose. Using a weigh tape to work out their horse's weight will help your clients avoid under dosing, which increases the risk of resistance development.
Pfizer says small redworms are the most common worms found in horses today. They can pose a very serious health risk to horses and it's important for owners to make sure that they are treated properly during the autumn or early winter.
Small redworms can grow up to 2.5cm in length and are thin and reddish in colour. Small redworm eggs are passed in the faeces and then hatch on pasture and continue to develop into more advanced larval stages before being ingested by the horse as it grazes. The larvae burrow deeply into the wall of the gut where they encyst and may account for up to 90% of the redworm burden in the horse1. Encysted small redworm will not show up in a Faecal Worm Egg Count - even if the horse has shown a negative or low count it could still be harbouring several million encysted small redworms2.
Encysted small redworms can remain dormant inside a horse for up to two years, but they usually 'wake-up' in late winter or early spring, developing and emerging from the gut wall all at the same time. In severe infestations mass emergence can lead to a disease syndrome known as 'larval cyathostominosis', causing diarrhoea and colic with up to a 50% mortality rate3. Young horses of less than six years of age can often be at higher risk of the disease3 but small redworm can cause life-threatening illness at any time of year and in any age of horse.
Ben Gaskell, Pfizer's veterinary adviser said: "Treating encysted small redworms successfully in the late autumn or early winter is important to avoid the risk of larval cyathostominosis. It's important to advise your customers to choose a product that is licensed to treat the worms they are targeting and that they give the correct dose, by weighing their horse beforehand, as this will help preserve the efficacy of the drug used."
Pfizer's Does your wormer measure up campaign is backed with point of sale materials and a media campaign. To receive a free weigh tape, valued at £7 your clients need to buy a tube of Equest or Equest Pramox, fill in an application form and send Pfizer the batch and expiry flap from the pack. Pfizer will then send them a FREE Weigh Tape while stocks last.
For further information contact your Pfizer Account Manager.
References
1. Bairden K. et al (2001) Veterinary Record 148, 138-1412. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑2423. McWilliam H. et al (2010) International Journal for Parasitology 40, 265-275
Carl Padgett has been elected President of the British Veterinary Association for 2011/2012.
Carl graduated from Glasgow University in 1989 and spent most of his career as a large animal practitioner. He is now a director of Bay Vets Ltd in Lancaster, and has particular interests in cattle health, production and welfare, veterinary politics and the role the profession has to play in the wider livestock industry and the companion animal world.
A former president of the British Cattle Veterinary Association (BCVA) and recent Chairman of Trustees of the BVA Animal Welfare Foundation, Carl has been involved in veterinary politics for over 15 years.
Carl said: "My representative roles for BVA, and prior to that BCVA, have enabled me to understand and realise my interest in the veterinary profession: ensuring the profession has a voice and our place in society is valued.
"Our multi-disciplinary education and training places the profession in a unique position to deliver a healthy future at many levels: representing the health and welfare of animals committed to our care, protecting the consumer by ensuring food safety and security at national and international levels by working within the agricultural world and ensuring public health in a variety of ways. Vets are not just part of the leisure industry making animals better; we fill a much wider role in underpinning society and its contact with animals at all levels."And so to the future. Although we do indeed live in a changing world, many of the challenges we face as a profession continue through from one President to the next, as they span beyond the year-long term of office. Over the last couple of years BVA has made a lot of progress on a number of policy issues and, in some instances, our lobbying efforts have paid off with Government announcements and new legislation reflecting our endeavours. Looking ahead, much of the coming year will be about putting those policies into practice, and that's why the theme of my presidential year will be 'Delivering a healthy future'.
"I am proud and honoured to be elected BVA President to continue serving the membership as part of the BVA Officer team."
Peter Harlech Jones was elected BVA President-elect for 2011/2012 at the same time.
The RCVS Charitable Trust is offering up to 10 grants worth around £500 each, to support UK veterinary surgeons looking to pursue themes of clinical or non-clinical research involving short-term visits to veterinary or medical centres, or research institutes, outside the UK.
The Travel Awards are open to registered members of the RCVS, as well as to candidates registered for a PhD at a UK veterinary school. The awards are available for up to 12 months from the award date, and awards cannot be made for projects taking place before 31 October 2011.
The successful candidates will be asked to submit an article to the veterinary press and provide the Trust with a diary record including photographs, and/or short video.
All applications must be received by 5pm on Monday 31 October 2011.
Further information including full application criteria, is available from www.rcvstrust.org.uk/grants/
Alternative, contact grants@rcvstrust.org.uk or call 0207 202 0741.
Eurovet Animal Health has launched a new product, Bovocycline 2000 mg pessary for cattle.
Bovocycline 2000 is the only veterinary licenced antibiotic pessary for the treatment of retained foetal membranes in cattle. It is licenced for the treatment of post parturient disorders in cattle, for administration after dystocia, retained foetal membranes (RFMs) and endometritis.
According to Eurovet, the incidence of retained foetal membranes in cows varies from zero to 25 per cent, but the average is around 4 per cent in most herds. RFMs result in reduced cow fertility and a higher risk of culling due to poor fertility. Pessaries are still considered the preferred treatment for vulval discharges in cattle by farmers.
Ruth Vernon, Technical Services Manager for Eurovet said: "The control of post partum problems in cattle is rarely straight forward, but it is great to have a veterinary licensed treatment designed specifically for this purpose, in one pessary that contains 2000mgs tetracycline".
For more information please contact Eurovet Animal Health. Tel: 01223 257933. E-mail: office@eurovet-ah.co.uk www.eurovet-ah.co.uk
The Veterinary Marketing Association has 10 tickets available for its annual debate being held at the House of Lords on Tuesday October 12th, this year entitled: Internet Pharmacies - Opportunity or Threat?
The debate will be chaired by Professor Sandy Trees, and the panel will comprise:
The debate kicks off at 10:30am, and is followed by lunch at 12:30pm on the famous terrace, overlooking the Thames.
VetSurgeon members may buy tickets at the lower VMA member price of £120 + VAT, which includes the champagne reception and three course lunch with wine.
Click here for more information.
Norbrook is expanding its NSAID range with the launch of Loxicom Injection for cattle, pigs and horses.
Norbrook says the new product, which will be available to veterinary surgeons from mid-October, offers treatment for a range of symptoms including pneumonia, acute mastitis and calf scour in cattle, swine locomotor diseases such as lameness and MMA syndrome, acute and chronic musculo-skeletal disorders and equine colic.
Rebecca Pullon, Norbrook Product Manager said: "Loxicom is our tried and trusted NSAID range which has been available in suspension or injection for cats and dogs and which has proven exceptionally popular with veterinary practices. According to the GFK data, Norbrook is the most successful generic manufacturer of Meloxicam, by some distance.
"I am delighted that we can now extend this range to include a Loxicom Injection for Cattle, Pigs and Horses, which I am confident will prove equally as popular."
"As a bio-equivalent product, Loxicom Injection for cattle, pigs and horses is as effective as the pioneer product. There is a misperception that a bioequivalent product is somehow inferior to the pioneer product, which is untrue. In order to attain a license, a company must prove that a bio-equivalent product is at least as effective as the pioneer. With Loxicom Injection for cattle, pigs and horses, it comes with the added reassurance that it has been produced by Norbrook, a world leader in animal health and veterinary pharmaceuticals manufacture."
The first steps have begun to find Petplan and The Veterinary Business Journal's Practice Manager of the Year for 2012.
Nominations are now being sought for the most accomplished UK practice managers and recommendations are welcome from any member of the veterinary team.
Three finalists will be chosen and the winner announced at the annual Petplan Veterinary Awards in April 2012.
Robin Fearon, editor of the Veterinary Business Journal, said: "It is a distinct pleasure to launch the awards programme each year knowing that at the end of it we will be able to announce another winning practice manager.
"These awards are so important in promoting the role and highlighting the crucial part that managers play in practice strategy and success - we can't wait to see your nominations."
Judges will assess candidates' applications and choose the three finalists based on their competency in areas such as staff development, financial strategy and marketing initiative.
Last year's winner Denise Coston is practice manager at Castle Veterinary Surgeons in County Durham. She said: "Winning this award has meant a lot to me because it makes you feel valued. I would say to anyone thinking of nominating their practice manager: 'just do it'.
"The role of practice manager varies in each practice and can be hard to quantify with specific measures, but it means a lot to celebrate someone getting it right. It is an excellent way to promote the role of practice manager and it is great to get recognition alongside vets and nurses."
This award is supported by the Society of Practising Veterinary Surgeons and the Veterinary Practice Management Association.
As well as a plaque commemorating their achievements, the winner will once more receive one year's free membership to the VPMA.
Nominations for this year's award close on 10 February 2012. Application packs are available from: Jackie Morrison, The Veterinary Business Journal, Olympus House, Werrington Centre, Peterborough PE4 6NA, or e-mail jackiemorrison@vbd.uk.com.
Alternatively visit www.vetsonline.com/ to download yours direct.
Dogs Trust, the UK's largest dog welfare charity, has teamed up with leading cardiac rehabilitation experts at Harefield Hospital to help patients in their final phase of coronary recovery.
The recovery programme, Hounds Help Hearts, is, according to the charity, a UK first and encourages post coronary patients to walk dogs as part of their recovery.
The Cardiac Rehabilitation team at Harefield Hospital aims to improve the physical, social and psychological well being of people after a heart attack or similar cardiac event. Among the recommendations for an ongoing healthy lifestyle, patients are being introduced to Dogs Trust Harefield where they can help staff, canine residents and themselves by walking some of the 150 dogs in their care. The charity hopes that heart hospitals UK wide will follow suit.
Hounds Help Hearts is part of a wider initiative to promote The Dog Prescription - a research document that highlights the ways dogs can improve human health. Dogs Trust is urging GPs all over the UK to prescribe a daily dose of dog with The Dog Prescription after research highlights the health benefits of dog ownership for both children and adults.
Lynda Evans, senior nurse /modern matron at Royal Brompton & Harefield NHS Foundation Trust, said: "Walking is one of the best forms of exercise for patients recovering from a cardiac event and what better way to do it than alongside a grateful canine companion. We have been running the 'Care For Your Heart' Rehabilitation Programme for more than 20 years and as a leading specialist heart and lung hospital we are always looking for new ways to help patients to enjoy the best possible quality of life when they return home. We are delighted to be working with Dogs Trust on this initiative and partnering patients with dogs to help them reach their full potential through interaction and physical exercise."
The Dog Prescription highlights the mental and physical benefits of dog ownership and interaction and names dog ownership as an aid to the recovery of post coronary patients
Clarissa Baldwin, Dogs Trust CEO said: "We undertook this research as we were aware of the health benefits of dog ownership but wanted to fully evaluate its potential. Amongst its ten points (which are not exhaustive), the prescription details health benefits including the fact that dogs can aid the recovery of post coronary patients. We want to spread the word about the health benefits of dogs and we hope that GPs and hospitals will start to encourage patients to engage with dogs for a healthier and happier lifestyle"
You can read the full research here.
Invicta Animal Health has announced its appointment as exclusive veterinary distributor in the UK for Chloraprep, a licensed human product for cutaneous antisepsis, prior to invasive procedures.
Invicta says Chloraprep is a single use, easy to apply, sterile system, available in a variety of sizes and in clear and tinted versions to enhance the visibility of the area requiring antisepsis, for instance, prior to surgery.
The sterile solution is maintained in a glass ampoule inside a protective outer case and, to prevent contamination, the patented design ensures users don't come into contact with either the contents or the patient's skin.
Rob Watkins, Managing Director of Invicta, said: "Most surgical site infections (SSI's) are the result of contamination from a patient's own skin flora1, a fact which highlights the importance of thorough and effective preparation of the skin as a proactive way to minimise the incidence of SSI's in patients."
According to the company, research has shown that Chloraprep, which contains 2% chlorhexidine and 70% isopropyl alcohol, has demonstrated significantly better antimicrobial activity than other combinations2.
Invicta says the way in which the solution is applied to the skin is as important as the solution itself. Studies show that the most effective way to apply Chloraprep is with a back and forth scrubbing movement because this gives a lower microbial count on the skin than using other application methods3. Once applied, Chloraprep is active in 30 seconds and is effective for up to 48 hours4.
Rob said: "The majority of UK hospitals and the Blood Transfusion Service already use Chloraprep and we are pleased to make this available under the provisions of the cascade."
He added: 'The veterinary nurses I've spoken to love this product, because they're fed up of immersing their dry, cracked hands in disinfectant!'
For further information, please contact Invicta Animal Health on 01403 791313 or email the company at mail@invictavet.com.
1. Florman S, Nichols RL. Am J Infect Dis 2007; 3: 51-61.2. Hibbard JS. J Infus Nurs 2005; 28: 194-207.3. Rosenthal K. Nurs Manage 2006; April: 55-66.4. Garcia R et al. Abstracts of the IDSA 40th Annual Meeting 2002; Abs 418.